Reproductive Health

OvaryIt Launches Telehealth Platform to Help Women Choose the Right Contraception

Earlier this week OvaryIt announced the launch of its OvaryIt platform to provide telehealth solutions for women seeking focused specialty care related to hormonal and non-hormonal contraception. Using OvaryIt’s network of independent physicians and its proprietary platform (using the latest cryptographic safety and privacy features), women can safely and confidently engage through a telehealth interface.  From the moment you first log in,…

Kegg’s Kristina Cahojova: “Tenacity is your business card. “

In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share kegg‘s founding story as told by founder Kristina Cahojova. kegg’s mission…

Rhia Ventures Invests in OCON Healthcare’s Ballerine, the First 3D Spherical Copper Intrauterine Contraceptive

Rhia Ventures has invested in Israel-based OCON Healthcare to assist the US launch of Ballerine, the first and only 3D spherical copper IUB (Intrauterine Ball). Ballerine’s unique shape reduces irritation to the endometrium with fewer malpositions and perforations, which are significant drawbacks associated with current T-shaped IUDs. The financing will also help expand Phase II clinical trials for OCON’s SEAD product, which offers point-of-care…

The U.S. Department of Veterans Affairs Awards Contract to Evofem Biosciences for Phexxi Contraceptive Gel

Evofem Biosciences has announced that the U.S. Department of Veterans Affairs has awarded the Company a contract for the purchase of Phexxi for a five-year period beginning December 15, 2020. Saundra Pelletier, CEO of Evofem Biosciences, said, “This award is an important milestone in our ongoing effort to create the broadest access to Phexxi for all patients.  We have achieved coverage for 55% of…

Twentyeight Health’s Amy Fan: “I wanted to bring the human-centric approach from beauty to healthcare, reimagining patient experiences to be simple, dignified, and approachable.”

In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share Twentyeight Health’s founding story as told by co-founder Amy Fan. Twentyeight…

Twentyeight Health Will Join Healthify’s SDoH Network to Provide Low- and No-Cost Birth Control to People in Need

Healthify, a company that works with managed care organizations to integrate social determinants of health (SDoH) into the healthcare ecosystem, has announced that Twentyeight Health, a femtech startup that provides affordable and convenient reproductive and sexual care, is joining its network of community-based organizations working to address social needs and improve outcomes for disadvantaged populations. “We are very excited to be partnering with…

Starter Story: How Talking Contraception over Dinner Led Alice Pelton to Founding Femtech Startup The Lowdown

In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share The Lowdown’s founding story as told by co-founder Alice Pelton.…

Contraline Receives $1M Investment from the Male Contraceptive Initiative to further Developement of ADAM, an “IUD for Men”

Male Contraceptive Initiative, a 501(c)(3) non-profit, today announced that it has partnered with the medical device company Contraline to provide a $1 million Program Related Investment to support a first-in-human clinical trial for the company’s novel vas-occlusive contraceptive device, ADAM™. This is the first PRI from Male Contraceptive Initiative and is representative of the organization’s continued evolution. “We are very excited about…